As Broad Shutdowns Return, Weary Californians Ask ‘Is This the Best We Can Do?’
California’s ping-ponging approach to managing the pandemic — twice reopening large portions of the service sector economy only to shut them again — has residents and business owners on edge. But experts say the push and pull on businesses may be what success looks like in much of the U.S. for months to come, given COVID-19’s pervasive spread.
Anger After North Dakota Governor Asks COVID-Positive Health Staff to Stay on Job
Doctors and nurses say order puts lives in danger, amid a COVID surge and a statewide shortage of health care workers.
Public Health Programs See Surge in Students Amid Pandemic
Catalyzed by the paltry response to the pandemic and the inequities it is causing, people are flocking to graduate programs in public health to become the next front-line workers.
Facebook Live: Helping COVID’s Secondary Victims: Grieving Families and Friends
More than 246,000 people in the U.S. have been killed by the coronavirus, leaving hundreds of thousands of others grieving. Judith Graham, author of KHN’s Navigating Aging column, hosted a discussion on these unprecedented losses and dealing with bereavement. She was joined by Holly Prigerson, co-director of the Center for Research on End-of-Life Care at Weill Cornell Medicine in New York City, and Diane Snyder-Cowan, leader of the bereavement professionals steering committee of the National Council of Hospice and Palliative Professionals.
Homeless Shelters Grapple With COVID Safety as Cold Creeps In
During the pandemic, shelters are having to change the way they do things to prevent the virus from spreading among the vulnerable homeless population. Now, as winter weather moves in, there’s less room at the shelters for those in need — threatening to leave many, literally, out in the cold.
Long-Term Care Workers, Grieving and Under Siege, Brace for COVID’s Next Round
As the coronavirus surges around the country, workers in nursing homes and assisted living centers are watching cases rise in long-term care facilities with a sense of dread. Many of these workers struggle with grief over the suffering they’ve witnessed.
‘Breakthrough Finding’ Reveals Why Certain COVID Patients Die
Scientists have found that some people have antibodies against parts of their own immune system, allowing viruses to multiply rapidly.
Stanford vs. Harvard: Two Famous Biz Schools’ Opposing Tactics on COVID
While the Harvard Business School gently chided returnees to be on their best behavior, Stanford deployed green-vested enforcers and campus police who sometimes threatened students if they violated the rules. Both, apparently, succeeded.
Clots, Strokes and Rashes: Is COVID a Disease of the Blood Vessels?
COVID-19 can cause symptoms that go well beyond the lungs, from strokes to organ failure. To explain these widespread injuries, researchers are studying how the virus affects the vascular system.
KHN’s ‘What the Health?’: Transition Interrupted
Former Vice President Joe Biden is now the president-elect nearly everywhere but inside the Trump administration, where the president refuses to concede and has ordered officials not to begin a formal transition. That is a particular problem for health care as the COVID-19 pandemic surges. Meanwhile, there’s good news on the vaccine front, but it’s unlikely one will arrive by winter. And the ACA was back before the Supreme Court — again. Joanne Kenen of Politico, Stephanie Armour of The Wall Street Journal and Shefali Luthra of the 19th News join KHN’s Julie Rovner to discuss these issues and more. Plus, for extra credit, the panelists recommend their favorite health stories of the week they think you should read, too.
Dicen que hay que informar a los consumidores, para que se preparen para efectos secundarios que, en realidad, pueden significar que las vacunas funcionan.
Time to Discuss Potentially Unpleasant Side Effects of COVID Shots? Scientists Say Yes.
From the likelihood of achy, flu-like side effects to the need for two doses, weeks apart, consumers need to know now what to expect when vaccines to prevent COVID-19 roll out.
Workers Who Lost Jobs Due to COVID May Need Help Getting Coverage This Fall
Millions of people have lost their jobs and health insurance since March, and experts say many of those looking for a plan on the ACA marketplace may not be able to get the assistance they need.
Nursing Homes Still See Dangerously Long Waits for COVID Test Results
The Trump administration hailed rapid tests as the way to halt COVID’s spread in nursing homes. A KHN analysis of federal data shows they’re not being used, as questions linger about accuracy and best practices.
When False Information Goes Viral, COVID-19 Patient Groups Fight Back
Fear and uncertainty about the coronavirus have made online patient support groups fertile ground for the spread of misinformation. But some in these groups make fact-checking a part of the mission to support fellow COVID sufferers.
Cinco preguntas críticas sobre la vacuna contra COVID-19 de Pfizer
La farmacéutica anunció que en una muestra pequeña se comprobó que podría prevenir la infección en nueve de cada 10 casos. Pero se necesitan más respuestas.
Five Important Questions About Pfizer’s COVID-19 Vaccine
The drugmaker says its mRNA vaccine worked in 90% of patients in its trial, but some observers question how long immunity will last and who will benefit.
Condado de Orange lucha por la equidad en salud y contra las restricciones estatales
El parque de diversiones más popular de California es el centro de una lucha sobre la mejor manera de contener COVID-19, al mismo tiempo que se trata de mantener la economía a flote.
Orange County Struggles With Health Equity — And Battles State Restrictions
Disneyland can’t reopen until Orange County’s coronavirus infection rates improve — especially among its poorest and most vulnerable residents. Local officials are protesting the requirements, saying the economy will suffer, and residents’ health along with it.
Búsqueda de un suero antiofídico también podría conducir a un tratamiento para COVID
El varespladib, un medicamento contra la mordedura de serpientes, tiene un efecto positivo en el síndrome de dificultad respiratoria aguda asociado con COVID-19.
